Cognizant, the U.S.-based IT services firm, reported a strong Q2 FY25 performance with better-than-expected revenue growth driven by large deals and demand in the BFSI sector. However, the firm’s overreliance on acquisitions and soft organic growth raises sustainability concerns.
Cognizant Technology Solutions Corp., the U.S.-based IT services leader, reported a robust second-quarter performance for FY25, supported by strong traction in its Banking, Financial Services, and Insurance (BFSI) vertical. Despite the revenue beat, investor sentiment remains tempered by the company’s growing reliance on acquisitions and mounting pressure on profitability.
Cognizant posted $5.25 billion in revenue, up 2.54% quarter-over-quarter and 8.14% year-over-year, exceeding analyst expectations. Notably, the BFSI segment contributed over 60% of the $130 million in incremental quarterly revenue, underscoring the firm’s deepening ties with global banking clients.
While other leading Indian IT companies posted mixed growth for the same period, Cognizant maintained its momentum. The company operates on a January-December fiscal calendar, unlike many Indian peers, making direct comparisons limited but still insightful.
Executives expressed confidence in the market’s direction, highlighting a shift toward innovation-led contracts.
We are starting to see new spending cycles from clients, particularly those aligned with innovation and digital transformation.”
CEO Ravi Kumar Singisetti, Cognizant
The firm raised its full-year guidance to between $20.7 billion and $21.1 billion, translating to an annual growth of 4.7% to 6.7%, citing a 6% increase in bookings year-over-year to $27.8 billion, its strongest in five quarters. These were anchored by two large deals valued over $500 million each, in the healthcare and telecom verticals.
Also Read: Cognizant’s 2024 Revenue Rise Driven by Strategic Acquisitions
Revenue Guidance Raised Amid Strong Deal Momentum
Reliance on Acquisitions Raises Sustainability Questions
Despite top-line growth, Cognizant’s increasing dependence on acquisitions is raising eyebrows. The Belcan acquisition, completed in August 2024 for $1.3 billion, contributed to nearly 50% of the company’s YoY growth. This trend mirrors the previous quarter and signals softening organic momentum.
In Q2, revenue from Belcan—a U.S.-based engineering services firm—contributed approximately 4 percentage points to the overall growth. That figure nearly eclipses growth rates reported by rivals with organically-driven models, intensifying concerns about long-term sustainability.
The Thirdera and Belcan acquisitions combined contributed a significant share in Q1 as well. Such dependence on inorganic drivers could pose a challenge as cost synergies diminish and integration complexities rise.
Margin Compression and Tax Impact Weigh on Profitability
Cognizant’s operating margin declined to 15.6%, from 16.7% in Q1, partly impacted by the absence of one-off gains like the $62 million office sale recorded in the previous quarter. Net profit also slipped by 2.7% sequentially to $645 million, signaling margin compression.
Comparative industry trends show TCS improving margins slightly, while others reported compressions similar to Cognizant. As price pressures persist and discretionary spending remains limited, sustaining profitability may require stronger cost optimization efforts.
Additionally, a one-time tax hit of $400 million is anticipated in Q3 FY25 due to recent U.S. tax law changes, further weighing on bottom-line prospects.
Sector-Specific Weakness Evident in Healthcare Vertical
Cognizant’s healthcare vertical, accounting for nearly one-third of total revenue, witnessed a 1.27% decline to $1.55 billion. Regulatory uncertainties and macro concerns in the U.S. healthcare space contributed to this softness.
Workforce Expansion Signals Growth Expectations
The company remains aggressive on hiring, adding 7,500 employees in the quarter, taking total headcount to 343,800. This figure surpasses peers, reflecting expectations of continued deal ramp-ups. Whether this workforce growth aligns with long-term deal conversions remains to be seen.
While Cognizant has succeeded in winning high-value deals and strengthening its BFSI portfolio, its dependency on acquisitions, weak organic growth, and declining margins raise red flags. The revised revenue outlook offers optimism, but investors are likely to remain cautious until structural growth trends stabilize.
For Cognizant, the path forward will depend on balancing acquisition-led expansion with organic innovation, improving margin efficiency, and navigating sector-specific challenges, especially in healthcare and regulated industries.
READ MORE ON
